These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)]. National Immunization Advisory Committee Technical Working Group. Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct 06; 54(10):1035-1059. PubMed ID: 33131228 [Abstract] [Full Text] [Related]
3. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults. Carter NJ, Curran MP. Drugs; 2011 Aug 20; 71(12):1591-622. PubMed ID: 21861544 [Abstract] [Full Text] [Related]
4. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003 Aug 20; 4(5):312-9. PubMed ID: 12952502 [Abstract] [Full Text] [Related]
5. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study. Simpson CR, Lone NI, Kavanagh K, Englishby T, Robertson C, McMenamin J, Wissman BV, Vasileiou E, Butler CC, Ritchie LD, Gunson R, Schwarze J, Sheikh A. Health Technol Assess; 2020 Dec 20; 24(67):1-66. PubMed ID: 33256892 [Abstract] [Full Text] [Related]
6. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG. Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct 10; 41(10):1555-1576. PubMed ID: 33297613 [Abstract] [Full Text] [Related]
7. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP. Pediatrics; 2005 Sep 10; 116(3):e397-407. PubMed ID: 16140685 [Abstract] [Full Text] [Related]
8. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG. Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct 10; 42(10):1722-1749. PubMed ID: 34814607 [Abstract] [Full Text] [Related]
9. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Pediatrics; 2006 Sep 10; 118(3):e579-85. PubMed ID: 16950949 [Abstract] [Full Text] [Related]
10. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination. Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct 06; 56(10):1356-1386. PubMed ID: 36274602 [Abstract] [Full Text] [Related]
11. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG. Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct 10; 43(10):1515-1544. PubMed ID: 36456484 [Abstract] [Full Text] [Related]
12. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM. J Infect Dis; 2011 Nov 15; 204(10):1475-82. PubMed ID: 21949042 [Abstract] [Full Text] [Related]
13. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG. Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct 10; 44(10):1507-1530. PubMed ID: 37875437 [Abstract] [Full Text] [Related]
14. [Technical guidelines for seasonal influenza vaccination in China, 2019-2020]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG. Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov 10; 40(11):1333-1349. PubMed ID: 31838802 [Abstract] [Full Text] [Related]
15. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Vaccine; 2010 Feb 25; 28(9):2149-56. PubMed ID: 20003926 [Abstract] [Full Text] [Related]
16. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Ambrose CS, Levin MJ, Belshe RB. Influenza Other Respir Viruses; 2011 Mar 25; 5(2):67-75. PubMed ID: 21306569 [Abstract] [Full Text] [Related]
17. Effectiveness and safety of influenza vaccination in children: European perspective. Heikkinen T, Heinonen S. Vaccine; 2011 Oct 06; 29(43):7529-34. PubMed ID: 21820481 [Abstract] [Full Text] [Related]
18. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP. Pediatrics; 2007 Sep 06; 120(3):e553-64. PubMed ID: 17698577 [Abstract] [Full Text] [Related]
19. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J. Vaccine; 2009 Feb 11; 27(7):1101-10. PubMed ID: 19095024 [Abstract] [Full Text] [Related]
20. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice. Prescrire Int; 2013 Sep 11; 22(141):201-4. PubMed ID: 24171209 [Abstract] [Full Text] [Related] Page: [Next] [New Search]